Yahoo

Arcosa (ACA) Could Be 1% Undervalued As Valuation Debate Follows Q2 2026 Results

Trade Arcosa on Coinbase

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.

Arcosa (ACA) reported second quarter 2026 results that highlighted steady sales and a sharp change in reported earnings, which now give investors fresh context for the stock's recent performance.

See our latest analysis for Arcosa.

Arcosa's recent earnings release lands after a strong run in the stock, with the 90 day share price return of 23.69% and year to date share price return of 35.79% sitting alongside a 1 year total shareholder return of 49.87%. This suggests momentum has been building over both shorter and longer periods.

If Arcosa's move has you thinking about where else growth and infrastructure trends might show up in markets, it could be a good time to scan for opportunities in power grid technology and infrastructure using the Simply Wall St screener, starting with the 40 power grid technology and infrastructure stocks .

After Arcosa's strong share price run and the narrow gap between the current price and analyst targets, the real tension is where fair value sits inside a wide range of estimates. How far does that spread really stretch?

Most Popular Narrative: 1% Undervalued

Arcosa's most followed valuation narrative puts fair value at $146, which sits just above the recent $145.01 close and frames the stock as close to fully priced with a slight margin to that estimate.

Accelerating investment in grid modernization, data center development, and renewable energy integration is boosting demand for utility and transmission structures, leading to a record backlog and prompting capacity expansions expected to support higher earnings growth and margin accretion.

Read the complete narrative. Read the complete narrative.

Want to see what is built into that $146 fair value for Arcosa? The story leans heavily on margin uplift, earnings resilience, and a richer future profit multiple. Curious which financial levers need to keep working to support that view?

Result: Fair Value of $146 (ABOUT RIGHT)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Arcosa's reliance on government funded infrastructure work and ongoing acquisition execution means that shifts in public budgets or integration setbacks could quickly challenge this fair value story.

Find out about the key risks to this Arcosa narrative.

Another View on Arcosa's Valuation

While the popular Arcosa narrative circles around a fair value of about $146 based on earnings and multiples, the Simply Wall St DCF model points in a very different direction. On that cash flow view, Arcosa at $145.01 screens as overvalued compared with an estimated value of $52.17. Which story do you think fits your assumptions better?

Look into how the SWS DCF model arrives at its fair value.

ACA Discounted Cash Flow as at Aug 2026
ACA Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Arcosa for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 53 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of optimism and concern around Arcosa leaves you on the fence, move quickly to review the underlying data and form your own stance by checking the 2 key rewards and 1 important warning sign .

Looking for more ideas beyond Arcosa?

If Arcosa has sharpened your focus, do not stop here. Broader research using targeted stock lists can help you spot opportunities you might otherwise miss.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ACA .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: